1 |
Yau YK, Mak WYJ, Lui NSR, Ng WYR, Cheung CYK, Li YLA, Ching YLJ, Chin ML, Lau HSL, Chan KLF, Chan KSP, Ng SC. High prevalence of extended-spectrum beta-lactamase organisms and the COVID-19 pandemic impact on donor recruitment for fecal microbiota transplantation in Hong Kong. United European Gastroenterol J 2021;9:1027-38. [PMID: 34623758 DOI: 10.1002/ueg2.12160] [Reference Citation Analysis]
|
2 |
Verhaar BJH, Hendriksen HMA, de Leeuw FA, Doorduijn AS, van Leeuwenstijn M, Teunissen CE, Barkhof F, Scheltens P, Kraaij R, van Duijn CM, Nieuwdorp M, Muller M, van der Flier WM. Gut Microbiota Composition Is Related to AD Pathology. Front Immunol 2022;12:794519. [DOI: 10.3389/fimmu.2021.794519] [Reference Citation Analysis]
|
3 |
Ser HL, Letchumanan V, Goh BH, Wong SH, Lee LH. The Use of Fecal Microbiome Transplant in Treating Human Diseases: Too Early for Poop? Front Microbiol 2021;12:519836. [PMID: 34054740 DOI: 10.3389/fmicb.2021.519836] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
4 |
Estevinho MM. Stools' donor recruitment, a challenge in pandemic times. United European Gastroenterol J 2021;9:993-4. [PMID: 34687164 DOI: 10.1002/ueg2.12168] [Reference Citation Analysis]
|